By Joseph D. Bryant
The O’Neal Comprehensive Cancer Center at UAB is partnering with the GO2 Foundation for Lung Cancer in a study – together with Vanderbilt University Medical Center and Augusta University – to improve participation from Black communities in lung cancer clinical trials.
Studying Trial Determinants of Success is funded by grants awarded to GO2 Foundation from Genentech and Bristol Myers Squibb. The study aims to help investigators better understand barriers to clinical trial participation among African American patients in Alabama, Tennessee and Georgia. Researchers will develop programs to increase clinical trial participation among Black patients.
While participation in clinical trials by all cancer patients in the United States is extremely low, at about 8%, that rate is even lower among racial and ethnic minority groups. Blacks make up about 6% of participants in clinical trials.
The rest of the article can be found by clicking HERE to visit the Alabama NewsCenter website.
Alabama News Center
All news and articles are copyrighted to the respective authors and/or News Broadcasters. eWeatherNews is an independent Online News Aggregator
Read more from original source here…